Green light for new rules on veterinary medicines and medicated feed
The EU is introducing new and improved rules to step up the fight against antimicrobial resistance and improve the availability and safety of veterinary medicines and medicated feed. This will be of benefit to animal health and help boost the competitiveness of the EU veterinary pharmaceutical sector.
The Council yesterday adopted the animal medicines package including two new regulations on:
- veterinary medicinal products
- the manufacture, placing on the market and use of medicated feed
and changes to the existing rules laying down procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency.
This package is a major milestone in the fight against antimicrobial resistance: on the one hand antimicrobials and antibiotics will have to be used much more prudently than is the case now, and on the other hand we encourage the development of better medicines and medicated feed. It is a win-win for public health and the competitiveness of the EU pharmaceutical industry.Elisabeth Köstinger, Austrian Federal Minister for Sustainability and Tourism and President of the Council
The new rules on veterinary medicinal products:
- clarify and simplify the procedures through which a marketing authorisation can be granted to new medicines, thereby reducing the administrative burden for companies, especially small ones
- better frame the use of antimicrobials in animals by further limiting their use for animals that are not yet sick but may run the risk of falling ill, both in the case of prophylaxis and metaphylaxis
- provide for certain critical antimicrobials to be set aside for the treatment of certain infections in humans in order to preserve their effectiveness
- improve the protection of the European consumers against the risk of the spreading of AMR through imports of animals and products of animal origin
- strengthen pharmacovigilance and controls
The new rules on medicated feed:
- set out criteria for the approval of feed business operators and their obligations when manufacturing medicated feed
- lay down harmonised requirements in order to avoid cross contamination of a non target feed with active substances
- clarify the prescription and use of medicated feed containing antimicrobials in food-producing animals
- prohibit the use of medicated feed for prophylaxis
In addition, regulation 726/2004 that establishes the European Medicines Agency and the centralised procedure for the authorisation and supervision of medicinal products is adapted in order to avoid any overlap with the procedures laid down in the new regulation on veterinary medicinal products.
EU responds to antimicrobial resistance
The Council and the European Parliament now need to sign the adopted regulations. The signed texts will then be published in the EU Official Journal and will enter into force 20 days later. However, the new rules will only be fully operational as of end of 2021.
The animal medicines package is a package of three proposals for regulations updating the existing legislative framework for veterinary medicines and medicated feed by further tailoring it to the specificities of the animal health sector. While continuing to safeguard public and animal health, animal welfare, food safety and the environment, the package is aimed in particular at increasing the availability of veterinary medicines in the EU, improving the functioning of the EU market, reducing administrative burdens and fostering innovation.
- Regulation of the European Parliament and of the Council on veterinary medicinal products and repealing Directive 2001/82/EC
- Regulation of the European Parliament and of the Council on the manufacture, placing on the market and use of medicated feed, amending Regulation (EC) No 183/2005 of the European Parliament and of the Council and repealing Council Directive 90/167/EEC
- Regulation of the European Parliament and of the Council amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use
- Background: Animal medicines package
- Veterinary medicines: new EU rules to enhance availability and fight against antimicrobial resistance (press release, 13/06/2018)
- Medicated feed: Council's green light wraps up the animal medicines package (press release, 27/06/2018)
Latest News from
Opening ceremony of the 2019/2020 academic year at the College of Europe14/11/2019 13:20:00
Keynote speech given yesterday by President Donald Tusk
Wolfgang Schäuble: “Without European unification, there would be no German unity”14/11/2019 12:10:00
EP President David Sassoli and President of the German Bundestag Wolfgang Schäuble commemorated the fall of the Berlin Wall on 9 November 1989.
Poultry welfare at slaughter: hazards identified, measures proposed14/11/2019 11:10:00
EFSA has proposed measures to address the animal welfare hazards most commonly observed during the slaughter of poultry for food production and disease control.
Brexit: Citizens' rights remain a key priority for MEPs13/11/2019 13:10:00
The Brexit Steering Group met on Tuesday 12 November with several committees to look at the part of the Withdrawal Agreement on citizens' rights.
Defence cooperation: Council launches 13 new PESCO projects13/11/2019 11:20:00
Five of the new projects focus on training, covering areas such as cyber, diving, tactical, medical as well as chemical, biological, radiological and nuclear defence (CBRND) training. Other projects focus on enhancing EU collaborative actions as well as on capability development on sea, air and space.
International trends in central bank independence: the ECB’s perspective12/11/2019 15:10:00
Remarks by Yves Mersch, Member of the Executive Board of the ECB and Vice-Chair of the Supervisory Board of the ECB, Roundtable Discussion on Central Bank Independence.
A tale of two money markets: fragmentation or concentration12/11/2019 14:10:00
Speech by Benoît Cœuré, Member of the Executive Board of the ECB, at the ECB workshop on money markets, monetary policy implementation and central bank balance sheets.
Turkey's illegal drilling activities in the Eastern Mediterranean12/11/2019 12:05:00
The Council has adopted a framework for restrictive measures in response to Turkey's unauthorised drilling activities in the Eastern Mediterranean. The framework will make it possible to sanction individuals or entities responsible for or involved in unauthorised drilling activities of hydrocarbons in the Eastern Mediterranean.
Vaccine against Ebola: EC grants first-ever market authorisation12/11/2019 11:20:00
The EC has adopted the decision granting marketing authorisation to the company Merck Sharp & Dohme B.V. for a vaccine against Ebola. This vaccine, called Ervebo, had been in development since the Ebola outbreak in West Africa in 2014. It is already used, as part of a specific protocol, to protect people at risk of infection, such as healthcare workers or people who have been exposed to infected persons.